Log In
Print
BCIQ
Print
Print this Print this
 

MTL-CEBPA (formerly MTL-501)

  Manage Alerts
Collapse Summary General Information
Company MiNA Therapeutics Ltd.
DescriptionSmall activating RNA (saRNA) targeting CEBPA gene formulated with lipid based nanoparticle
Molecular Target CCAAT enhancer binding protein alpha (CEBPA)
Mechanism of ActionGene therapy
Therapeutic ModalityNucleic acid: Linear RNA
Latest Stage of DevelopmentPreclinical
Standard IndicationLiver cancer
Indication DetailsTreat hepatocellular carcinoma (HCC)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today